← All trials
NCT04082364
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2019
- Primary completion
- May 31, 2024
- Completion date
- May 31, 2026
- First posted
- —
- Last posted
- —
- Enrollment
- 850
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- MacroGenicsLead sponsor
- MacroGenicsStudy director
- Zai Lab Pty. Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.